TrivarX Limited (ASX:TRI)
Australia · Delayed Price · Currency is AUD 0.0140
-0.0010 (-6.67%)
Sep 9, 2026, 4:10 PM AEST
TrivarX Market Cap
TrivarX has a market cap or net worth of 17.31 million as of September 9, 2026. Its market cap has increased by 193.89% in one year.
Market Cap
17.31M
Enterprise Value
14.99M
Revenue
14.57K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.01
ChartMarket Cap Chart
Since July 2, 2001, TrivarX's market cap has increased from 11.57M to 17.31M, an increase of 49.59%. That is a compound annual growth rate of 1.61%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 8, 2026 | 17.31M | -21.05% |
| Dec 31, 2025 | 21.92M | 194.71% |
| Dec 30, 2024 | 7.44M | -26.66% |
| Dec 29, 2023 | 10.14M | 52.72% |
| Dec 28, 2022 | 6.64M | -41.41% |
| Dec 30, 2021 | 11.34M | 5.14% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Pharmx Technologies | 58.62M |
| Pathkey.AI | 49.97M |
| Doctor Care Anywhere Group | 47.66M |
| Emyria | 37.10M |
| Beamtree Holdings | 33.40M |
| Vitasora Health | 28.09M |
| Resonance Health | 27.20M |
| PainChek | 22.99M |